pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
onclive·May 13·1 min read
save

UCSF receives $100 million gift to fund capital projects, cancer research and hospital modernization

May 13, 2026·read at onclive ↗DealPositive

Longtime supporters Kathy Chiao and Kenneth Hao have pledged $100 million to the University of California, San Francisco. The commitment is intended to address the university’s most urgent capital needs and to speed up innovation that benefits human health.

The flexible funding will be used for capital expansion across the UCSF campus, priority-driven innovation projects, and the Weill Cancer Hub West, which aims to accelerate cancer discovery and treatment development.

Modernization plans include redevelopment of the Parnassus Heights campus, construction of the UCSF Health Helen Diller Hospital, and upgrades to the UCSF Benioff Children’s Hospital Oakland, adding 104 new inpatient beds and a dedicated 20-bed pediatric behavioral health unit.

The gift also supports the IMPACC program, which will study real-world safety, efficacy and equity of clinical artificial-intelligence tools, and it backs cross-campus translational initiatives that link human and veterinary medicine, building on a recent $75 million donation to UC Davis for veterinary research.

source

This writeup was produced by pharmadog from original reporting by onclive.

Original headline: “UCSF Receives Major Gift to Advance Research and Modernization”

read at onclive ↗
2,207 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
icosapent ethyl3Novel Therapeutic
topics
Oncology38Breast Cancer6Prostate Cancer6HER25NSCLC4TROP-23Antibody-Drug Conjugate (ADC)2Hematology2Oncolytic Virus2Radioligand Therapy2AMDAMLBispecific AntibodyDiabetic Macular EdemaEGFREndocrinology & MetabolismGlioblastomaImmunologyMelanomaMonoclonal AntibodyNeurologyPsychiatry & CNSPulmonologySmall Molecule

related stories

  • May 10Five Under 5: Top Oncology Videos for the Week of 5/3onclive
  • May 9The OncFive: Top Oncology Articles for the Week of 5/3onclive
  • May 8Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive
  • May 8Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhDonclive
  • May 8Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive